Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer

Published:2016-10-01 Issue:3 Volume:54 Page:733-741
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Latteyer Soeren,Tiedje Vera,König Katharina,Ting Saskia,Heukamp Lukas C.,Meder Lydia,Schmid Kurt Werner,Führer Dagmar,Moeller Lars Christian

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-016-1080-9.pdf

Reference49 articles.

1. J.P. O’Neill, A.R. Shaha, Anaplastic thyroid cancer. Oral Oncol. 49(7), 702–706 (2013). doi: 10.1016/j.oraloncology.2013.03.440

2. N. Pinto, M. Black, K. Patel, J. Yoo, J.S. Mymryk, J.W. Barrett, A.C. Nichols, Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer. J. Oncol. 2014, 936285 (2014). doi: 10.1155/2014/936285

3. R.C. Smallridge, K.B. Ain, S.L. Asa, K.C. Bible, J.D. Brierley, K.D. Burman, E. Kebebew, N.Y. Lee, Y.E. Nikiforov, M.S. Rosenthal, M.H. Shah, A.R. Shaha, R.M. Tuttle, American Thyroid Association Anaplastic Thyroid Cancer Guidelines, T., American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid : Official Journal of the American Thyroid Association 22(11), 1104–1139 (2012). doi: 10.1089/thy.2012.0302

4. M. Xing, Molecular pathogenesis and mechanisms of thyroid cancer. Nat. Rev. Cancer 13(3), 184–199 (2013). doi: 10.1038/nrc3431

5. G. Gauchotte, C. Philippe, S. Lacomme, B. Leotard, M.P. Wissler, L. Allou, B. Toussaint, M. Klein, J.M. Vignaud, A. Bressenot, BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis. Pathology 43(5), 447–452 (2011). doi: 10.1097/PAT.0b013e3283486178

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Survival of Advanced‐Stage Anaplastic Thyroid Cancer With Systemic Therapy;The Laryngoscope;2024-08-20

2. Schilddrüsenkarzinome – Rolle internistischer Systemtherapien;Die Innere Medizin;2024-06-20

3. Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy;Biomedicines;2024-06-12

4. Deciphering Molecular Signatures Behind Different Radioactive Iodine Uptake Patterns in Differentiated Thyroid Cancer with Distant Metastases;Clinical Thyroidology®;2024-06-01

5. Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer;Chinese Journal of Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3